Neil Vasan is an Oncology physician affiliated with Columbia University Irving Medical Center. OpenAlex indexes 113 publications with 6,396 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
160 E 34th St
New York, NY 100164744
Telephone
212-731-6000Provider last certified this registry record 16 Dec 2025.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Stemline Therapeutics Inc.Program year20251 payment
- Daiichi Sankyo Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2020–2024 per NIH RePORTER. The latest:
- Investigating a hierarchical model for PI3K activation and inhibition in breast cancer by double PIK3CA mutations in cis
Columbia University Health Sciences
FY2024$196,603K08CA245192 - Base-Editing the Cancer Kinome to Enable Drug Discovery
Columbia University Health Sciences
FY2023$1,480,500DP2CA290245 - Investigating a hierarchical model for PI3K activation and inhibition in breast cancer by double PIK3CA mutations in cis
Columbia University Health Sciences
FY2023$263,034K08CA245192
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- LIN28B-mediated PI3K/AKT pathway activation promotes metastasis in colorectal cancer models
Journal of Clinical Investigation
2025 - Continuous glucose monitoring to characterize hyperglycemia during chemotherapy for early stage breast cancer
Breast Cancer Research and Treatment
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Stanley Fahn, MD
Columbia University Irving Medical Center
Rebecca Hahn, MD
Columbia University Irving Medical Center
Susheel Kodali, MD
Columbia University Irving Medical Center
Ronald Wapner, MD
Columbia University Irving Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”